Logo image of PLAB

PHOTRONICS INC (PLAB) Stock Fundamental Analysis

NASDAQ:PLAB - Nasdaq - US7194051022 - Common Stock - Currency: USD

21.105  +0.41 (+1.96%)

After market: 21.105 0 (0%)

Fundamental Rating

6

Taking everything into account, PLAB scores 6 out of 10 in our fundamental rating. PLAB was compared to 107 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the health and profitability get an excellent rating, making PLAB a very profitable company, without any liquidiy or solvency issues. PLAB is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings could make PLAB a good candidate for value investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

PLAB had positive earnings in the past year.
PLAB had a positive operating cash flow in the past year.
In the past 5 years PLAB has always been profitable.
In the past 5 years PLAB always reported a positive cash flow from operatings.
PLAB Yearly Net Income VS EBIT VS OCF VS FCFPLAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

PLAB has a Return On Assets of 7.63%. This is in the better half of the industry: PLAB outperforms 72.90% of its industry peers.
The Return On Equity of PLAB (11.66%) is better than 70.09% of its industry peers.
Looking at the Return On Invested Capital, with a value of 10.75%, PLAB is in the better half of the industry, outperforming 79.44% of the companies in the same industry.
PLAB had an Average Return On Invested Capital over the past 3 years of 12.91%. This is in line with the industry average of 11.63%.
Industry RankSector Rank
ROA 7.63%
ROE 11.66%
ROIC 10.75%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
PLAB Yearly ROA, ROE, ROICPLAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

Looking at the Profit Margin, with a value of 15.07%, PLAB is in the better half of the industry, outperforming 72.90% of the companies in the same industry.
PLAB's Profit Margin has improved in the last couple of years.
The Operating Margin of PLAB (25.55%) is better than 85.05% of its industry peers.
In the last couple of years the Operating Margin of PLAB has grown nicely.
PLAB's Gross Margin of 36.44% is on the low side compared to the rest of the industry. PLAB is outperformed by 65.42% of its industry peers.
PLAB's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 25.55%
PM (TTM) 15.07%
GM 36.44%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
PLAB Yearly Profit, Operating, Gross MarginsPLAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), PLAB is creating some value.
The number of shares outstanding for PLAB has been increased compared to 1 year ago.
Compared to 5 years ago, PLAB has less shares outstanding
Compared to 1 year ago, PLAB has an improved debt to assets ratio.
PLAB Yearly Shares OutstandingPLAB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
PLAB Yearly Total Debt VS Total AssetsPLAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

PLAB has an Altman-Z score of 3.35. This indicates that PLAB is financially healthy and has little risk of bankruptcy at the moment.
PLAB's Altman-Z score of 3.35 is in line compared to the rest of the industry. PLAB outperforms 51.40% of its industry peers.
The Debt to FCF ratio of PLAB is 0.14, which is an excellent value as it means it would take PLAB, only 0.14 years of fcf income to pay off all of its debts.
PLAB has a better Debt to FCF ratio (0.14) than 85.98% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PLAB is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, PLAB is in the better half of the industry, outperforming 70.09% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.14
Altman-Z 3.35
ROIC/WACC0.94
WACC11.49%
PLAB Yearly LT Debt VS Equity VS FCFPLAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 5.07 indicates that PLAB has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.07, PLAB is in the better half of the industry, outperforming 78.50% of the companies in the same industry.
PLAB has a Quick Ratio of 4.76. This indicates that PLAB is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.76, PLAB belongs to the best of the industry, outperforming 83.18% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.07
Quick Ratio 4.76
PLAB Yearly Current Assets VS Current LiabilitesPLAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for PLAB have decreased by -2.94% in the last year.
Measured over the past years, PLAB shows a very strong growth in Earnings Per Share. The EPS has been growing by 33.90% on average per year.
Looking at the last year, PLAB shows a decrease in Revenue. The Revenue has decreased by -2.82% in the last year.
Measured over the past years, PLAB shows a quite strong growth in Revenue. The Revenue has been growing by 9.50% on average per year.
EPS 1Y (TTM)-2.94%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-18.06%
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.13%

3.2 Future

The Earnings Per Share is expected to grow by 8.85% on average over the next years. This is quite good.
Based on estimates for the next years, PLAB will show a small growth in Revenue. The Revenue will grow by 6.61% on average per year.
EPS Next Y8.18%
EPS Next 2Y8.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.11%
Revenue Next 2Y6.61%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PLAB Yearly Revenue VS EstimatesPLAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
PLAB Yearly EPS VS EstimatesPLAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

8

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.66, the valuation of PLAB can be described as very reasonable.
96.26% of the companies in the same industry are more expensive than PLAB, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of PLAB to the average of the S&P500 Index (29.36), we can say PLAB is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.85, the valuation of PLAB can be described as very reasonable.
Based on the Price/Forward Earnings ratio, PLAB is valued cheaper than 95.33% of the companies in the same industry.
PLAB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.65.
Industry RankSector Rank
PE 10.66
Fwd PE 9.85
PLAB Price Earnings VS Forward Price EarningsPLAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PLAB indicates a rather cheap valuation: PLAB is cheaper than 98.13% of the companies listed in the same industry.
99.07% of the companies in the same industry are more expensive than PLAB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.25
EV/EBITDA 2.12
PLAB Per share dataPLAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PLAB's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PLAB has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.3
PEG (5Y)0.31
EPS Next 2Y8.85%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for PLAB!.
Industry RankSector Rank
Dividend Yield N/A

PHOTRONICS INC

NASDAQ:PLAB (2/26/2025, 8:01:28 PM)

After market: 21.105 0 (0%)

21.105

+0.41 (+1.96%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)12-11 2024-12-11/bmo
Earnings (Next)02-26 2025-02-26/bmo
Inst Owners93.24%
Inst Owner Change-92.26%
Ins Owners3.79%
Ins Owner Change6%
Market Cap1.34B
Analysts82.86
Price Target35.7 (69.15%)
Short Float %3.39%
Short Ratio3.83
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.26%
Min EPS beat(2)-10.71%
Max EPS beat(2)11.24%
EPS beat(4)1
Avg EPS beat(4)-8.42%
Min EPS beat(4)-17.55%
Max EPS beat(4)11.24%
EPS beat(8)3
Avg EPS beat(8)-2.29%
EPS beat(12)6
Avg EPS beat(12)5.04%
EPS beat(16)9
Avg EPS beat(16)6.61%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.07%
Max Revenue beat(2)0.12%
Revenue beat(4)1
Avg Revenue beat(4)-4.86%
Min Revenue beat(4)-8.07%
Max Revenue beat(4)0.12%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)6
Avg Revenue beat(12)-0.68%
Revenue beat(16)7
Avg Revenue beat(16)-0.55%
PT rev (1m)0%
PT rev (3m)9.38%
EPS NQ rev (1m)3.3%
EPS NQ rev (3m)5.38%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.46%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.66%
Valuation
Industry RankSector Rank
PE 10.66
Fwd PE 9.85
P/S 1.54
P/FCF 10.25
P/OCF 5.11
P/B 1.19
P/tB 1.19
EV/EBITDA 2.12
EPS(TTM)1.98
EY9.38%
EPS(NY)2.14
Fwd EY10.15%
FCF(TTM)2.06
FCFY9.76%
OCF(TTM)4.13
OCFY19.56%
SpS13.69
BVpS17.7
TBVpS17.7
PEG (NY)1.3
PEG (5Y)0.31
Profitability
Industry RankSector Rank
ROA 7.63%
ROE 11.66%
ROCE 14.49%
ROIC 10.75%
ROICexc 18.5%
ROICexgc 18.5%
OM 25.55%
PM (TTM) 15.07%
GM 36.44%
FCFM 15.04%
ROA(3y)8.29%
ROA(5y)6.4%
ROE(3y)12.94%
ROE(5y)9.95%
ROIC(3y)12.91%
ROIC(5y)9.9%
ROICexc(3y)20.57%
ROICexc(5y)15.24%
ROICexgc(3y)20.57%
ROICexgc(5y)15.24%
ROCE(3y)17.42%
ROCE(5y)13.37%
ROICexcg growth 3Y30.41%
ROICexcg growth 5Y29.52%
ROICexc growth 3Y30.45%
ROICexc growth 5Y29.79%
OM growth 3Y21.48%
OM growth 5Y21.98%
PM growth 3Y21.78%
PM growth 5Y22.74%
GM growth 3Y13.15%
GM growth 5Y10.69%
F-Score5
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.14
Debt/EBITDA 0
Cap/Depr 158.24%
Cap/Sales 15.11%
Interest Coverage 250
Cash Conversion 85.91%
Profit Quality 99.79%
Current Ratio 5.07
Quick Ratio 4.76
Altman-Z 3.35
F-Score5
WACC11.49%
ROIC/WACC0.94
Cap/Depr(3y)153.58%
Cap/Depr(5y)131.47%
Cap/Sales(3y)14.5%
Cap/Sales(5y)14.32%
Profit Quality(3y)124.28%
Profit Quality(5y)132.15%
High Growth Momentum
Growth
EPS 1Y (TTM)-2.94%
EPS 3Y32.05%
EPS 5Y33.9%
EPS Q2Q%-18.06%
EPS Next Y8.18%
EPS Next 2Y8.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.82%
Revenue growth 3Y9.31%
Revenue growth 5Y9.5%
Sales Q2Q%-2.13%
Revenue Next Year6.11%
Revenue Next 2Y6.61%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-12.47%
EBIT growth 3Y32.79%
EBIT growth 5Y33.57%
EBIT Next Year43.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-23.63%
FCF growth 3Y46.47%
FCF growth 5YN/A
OCF growth 1Y-13.48%
OCF growth 3Y20.13%
OCF growth 5Y30.76%